First-Line ULT for Gout: Is a Mechanism-Based Approach Best?

Two gout experts debated whether first-line urate-lowering therapy should consist of a xanthine oxidase inhibitor or should instead be tailored to the mechanism of a patient’s hyperuricemia.
Medscape Medical News